Who Paid My Doc
Exkivity
Drug Oncology
NDC 63020-040-90
General payments
$796,138
Research payments
$1,427,597
Through program year 2025, $796,138 in general payments and $1,427,597 in research payments were reported against Exkivity (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $345,862 | 26 |
| 2024 | General | $5,558 | 4 |
| 2024 | Research | $627,666 | 88 |
| 2023 | General | $126,405 | 164 |
| 2022 | General | $360,771 | 929 |
| 2022 | Research | $454,069 | 2 |
| 2021 | General | $303,403 | 478 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
1,575 general · 116 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.